Pioglitazone prevents the increase in plasma ketone concentration associated with dapagliflozin in insulin‐treated T2DM patients: Results from the Qatar Study - Abdul‐Ghani - 2019 - Diabetes, Obesity and Metabolism - Wiley Online Library
Thiazolidinediones Cause Cardiotoxicity via PPARγ- Independent Mechanism | IntechOpen
Frontiers | The Pioglitazone Trek via Human PPAR Gamma: From Discovery to a Medicine at the FDA and Beyond | Pharmacology
Oral and Injectable (Non-Insulin) Pharmacological Agents for the Treatment of Type 2 Diabetes - Endotext - NCBI Bookshelf
PHARMACOLOGICAL MANAGEMENT OF DIABETES – OHA - ppt download
Pioglitazone
Pharmacological Differences of Glitazones: Does Peroxisome Proliferator-Activated Receptor-α Activation Make the Difference?⁎⁎Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily
MicroRNA miR-222 mediates pioglitazone beneficial effects on skeletal muscle of diet-induced obese mice - ScienceDirect
Synthesis of a novel glibenclamide-pioglitazone hybrid compound and its effects on glucose homeostasis in normal and insulin-resistant rats - ScienceDirect
Non-insulinotropic Diabetes Drugs | Concise Medical Knowledge
Thiazolidinedione | Actos | Avandia | Pioglitazone | Diabetes Medicine
Substrate flow and metabolome action sites of rosiglitazone,... | Download Scientific Diagram
Pioglitazone
Molecular mechanisms of action of thiazolidinediones. | Download Scientific Diagram
Pioglitazone-induced AMPK-Glutaminase-1 prevents high glucose-induced pancreatic β-cell dysfunction by glutathione antioxidant system - ScienceDirect
Proposed mechanism of action of pioglitazone. Pioglitazone increases... | Download Scientific Diagram
Thiazolidinediones and PPAR-γ mechanisms of action in the cell.... | Download Scientific Diagram